10x Genomics, Inc. (TXG) — Stock Score Summary

10x Genomics, Inc. (TXG) has a MoatMap StockRank of 95/100 based on Quality (59/100), Value (42/100), and Momentum (83/100) factor scores. The current signal is STRONG BUY. 10x Genomics is a high-growth life sciences company, but it is currently unprofitable and faces intense litigation and customer budget constraints, failing our margin of safety and quality compounder tests.

10x Genomics, Inc. develops and sells integrated systems, including instruments, consumables, and software, for advanced genomic analysis, specializing in single-cell and spatial biology. The company's competitive moat is derived from its proprietary technology platforms, which provide unprecedented resolution in biological research, establishing it as a market leader in these rapidly expanding fields. 10x Genomics is a key enabler for breakthroughs in genomics and biomedical discovery.

Key Financial Metrics

Price$32.16
Market Cap$3.6B
P/E (Forward)167.50
Price/Book5.37
Return on Equity-3.0%
Return on Invested Capital-4.5%
Debt/Equity9.99
Gross Margin69.7%
Operating Margin-11.3%
Revenue Growth-2.6%
Free Cash Flow$125M

10x Genomics, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is 10x Genomics, Inc.’s (TXG) StockRank?
MoatMap’s StockRank for 10x Genomics, Inc. (TXG) is 95/100, with a Strong Buy signal. It is a composite of Quality (59), Value (42), and Momentum (83) factor ranks across MoatMap’s 19,000+ stock universe.
Does 10x Genomics, Inc. have an economic moat?
10x Genomics, Inc. (TXG) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is 10x Genomics, Inc. a buy, hold, or sell?
MoatMap’s current signal for 10x Genomics, Inc. (TXG) is Strong Buy, based on a StockRank of 95/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is 10x Genomics, Inc. in?
10x Genomics, Inc. (TXG) operates in the Healthcare sector, specifically the Health Information Services industry (United States).
Browse all ranked stocksTXG deep dive reportAI ChampionsHow we score stocksSense-check another stock